Clinical Trial Update: Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes

View source ↗

Summary

A completed clinical trial evaluating hydroxyl free radical-related effects of SGLT-2 inhibitors in Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: University of Pecs | Conditions: T2DM | Status: COMPLETED